SGHT Q1 2024 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+2.3% YoY

Gross Profit

$16M85.5% margin

Operating Income

-$15M-76.4% margin

Net Income

-$16M-84.4% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$156M

Total Liabilities

$46M

Stockholders' Equity

$109M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$19M	+2.3%
Gross Profit	$16M	$16M	+4.4%
Operating Income	-$15M	-$18M	+16.2%
Net Income	-$16M	-$17M	+4.7%

Revenue Segments

Surgical Glaucoma

$18M95%

Dry Eye

$1M5%